Company intelligence / Profile preview

Danhson-BG

Sofia, Bulgaria

Ownership: Private
Development stage: Other

Overview

Danhson is a Bulgarian pharmaceutical company specializing in the development, production, and marketing of generic medicinal products, food supplements, and cosmetics. The company operates a modern manufacturing facility in Radomir, which is GMP-certified and equipped for various dosage forms including solids, semi-solids, and liquids. In addition to its own product portfolio, Danhson provides contract manufacturing (CMO/CDMO) services to international partners. Their therapeutic focus spans across pain relief, cardiovascular health, and respiratory treatments. The company maintains a strong presence in the Balkan region and exports to various international markets.

Therapeutic areas: CardiovascularImmunologyNeurologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Danhson-BG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Danhson-BG.

Explore the full profile